Skip to main content
Premium Trial:

Request an Annual Quote

NorDiag to Buy DNA Sample Prep Firm Genpoint for $13.3M

NEW YORK (GenomeWeb News) – Norwegian cancer diagnostics company NorDiag has signed a deal to buy DNA sample prep company Genpoint, also based in Norway, in a stock deal worth NOK 83.3 million ($13.3 million), NorDiag said last week.
NorDiag said the acquisition will expand its cancer and infectious diagnostics line and will help speed its colorectal cancer test to the market.
Under the agreement, NorDiag will exchange as much as 9.8 million of its own shares to acquire 90.1 percent of Genpoint's outstanding shares. Proceeds from the placement will fund new product roll-out and company growth, NorDiag said.
The company also plans to conduct a rights issue of shares for as much as NOK 10 million after the deal closes.
NorDiag's board will meet to approve the transaction on March 16. It also plans to name Jan Olav Steensland, J. Frode Vaksvik, and Mattias Uhlen as new board members.
Last year, Genpoint worked with NorDiag to help automate and improve NorDiag's DNA isolation capability.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.